The lacI Gene as a Target for Mutation in Transgenic Rodents and Escherichia coli

Corresponding author: Johan G. de Boer, Centre for Environmental Health, University of Victoria, P.O. Box 3020, Victoria, BC Canada V8W 3N5, jdboer{at}uvic.ca (E-mail).

The lacI gene has been used extensively for the recovery and analysis of mutations in bacteria with various DNA repair backgrounds and after exposure to a wide variety of mutagens. This has resulted in a large database of information on mutational mechanisms and specificity of many mutagens, as well as the effect of DNA repair background on mutagenicity. Most importantly, knowledge about the mutational sensitivity of the lacI gene is now available, yielding information about mutable nucleotides. This popularity and available knowledge resulted in the use of the lacI gene in transgenic rodents for the study of mutagenesis in mammals, where it resides in ~40 repeated copies. As the number of sequenced mutations recovered from these animals increases, we are able to analyze the sites at which mutations have been recovered in great detail and to compare the recovered sites between bacteria and transgenic animals. The nucleotides that code for the DNA-binding domain are nearly saturated with base substitutions. Even after determining the sequences of ~10,000 mutations recovered from the animals, however, new sites and new changes are still being recovered. In addition, we compare the nature of deletion mutations between bacteria and animals. Based on the nature of deletions in the animals, we conclude that each deletion occurs in a single copy of the gene.

This article has been cited by other articles:

				L. Caperton, P. Murphey, Y. Yamazaki, C. A. McMahan, C. A. Walter, R. Yanagimachi, and J. R. McCarrey From the Cover: Assisted reproductive technologies do not alter mutation frequency or spectrum PNAS, March 20, 2007; 104(12): 5085 - 5090. [Abstract] [Full Text] [PDF]

				L. Lehmann, H. L.Esch, P. A.Kirby, L. W.Robertson, and G. Ludewig 4-Monochlorobiphenyl (PCB3) induces mutations in the livers of transgenic Fisher 344 rats Carcinogenesis, February 1, 2007; 28(2): 471 - 478. [Abstract] [Full Text] [PDF]

				J.-H. Yoon, L. E. Smith, Z. Feng, M.-s. Tang, C.-S. Lee, and G. P. Pfeifer Methylated CpG Dinucleotides Are the Preferential Targets for G-to-T Transversion Mutations Induced by Benzo[a]pyrene Diol Epoxide in Mammalian Cells: Similarities with the p53 Mutation Spectrum in Smoking-associated Lung Cancers Cancer Res., October 1, 2001; 61(19): 7110 - 7117. [Abstract] [Full Text] [PDF]

				N. Watanabe, E. Okochi, Y. Hirayama, Y. Shimada, K. Yanagihara, M. C. Yoshida, S. Takahashi, M. Mochizuki, T. Sugimura, M. Nagao, et al. Single Nucleotide Instability without Microsatellite Instability in Rat Mammary Carcinomas Cancer Res., March 1, 2001; 61(6): 2632 - 2640. [Abstract] [Full Text]

				G. R. Stuart and B. W. Glickman Through a Glass, Darkly: Reflections of Mutation From lacI Transgenic Mice Genetics, July 1, 2000; 155(3): 1359 - 1367. [Abstract] [Full Text]

				G. R. Stuart, Y. Oda, J. G. de Boer, and B. W. Glickman Mutation Frequency and Specificity With Age in Liver, Bladder and Brain of lacI Transgenic Mice Genetics, March 1, 2000; 154(3): 1291 - 1300. [Abstract] [Full Text]